The molecular approach can be used when the targeted autoantigen is well known
The molecular approach can be used when the targeted autoantigen is well known. more prevalent in situations (95 of 390, 24%) than handles (3 of 60, 5%, = .001) but didn’t discriminate among pituitary illnesses when reported dichotomously. Nevertheless, when…